Coronary artery disease (CAD), a common cardiovascular disease, has become a vital cause of mortality worldwide. Genetic microRNA (miR) polymorphisms might contribute to CAD susceptibility. In this study, we selected miR-146a, miR-196a2, and miR-499 single nucleotide polymorphisms and conducted a case–control study. In total, 505 CAD cases and 1109 controls were recruited. We used SNPscan™ genotyping assay to obtain genotyping of miR rs2910164, rs11614913, and rs3746444 variants. We found that miR-196a2 rs11614913 T > C decreased the susceptibility of myocardial infarction (MI) (TC vs. TT: adjusted p = 0.007 and CC/TC vs. TT: adjusted p = 0.012). In female subgroup, our results indicated that miR-196a2 rs11614913 T > C variants might also decrease the susceptibility of CAD (TC vs. TT: adjusted p = 0.017 and TC/CC vs. TT: adjusted p = 0.015). In summary, these results suggest that miR-196a2 rs11614913 T > C locus decreases the susceptibility of CAD in female and MI subgroups. However, further studies are needed to validate the potential associations of miR-196a2 rs11614913 locus with CAD.
Get full access to this article
View all access options for this article.
References
1.
AfzalT.A., LuongL.A., ChenD., ZhangC., YangF., ChenQ., et al. (2016). NCK associated protein 1 modulated by miRNA-214 determines vascular smooth muscle cell migration, proliferation, and neointima hyperplasia. J Am Heart Assoc, 5, pii: e004629.
2.
AlbrektsenG., HeuchI., LochenM.L., ThelleD.S., WilsgaardT., NjolstadI., et al. (2017). Risk of incident myocardial infarction by gender: interactions with serum lipids, blood pressure and smoking. The Tromso Study 1979–2012. Atherosclerosis, 261, 52–59.
3.
AlipoorB., MeshkaniR., GhaediH., SharifiZ., PanahiG., and GolmohammadiT. (2016). Association of miR-146a rs2910164 and miR-149 rs2292832 variants with susceptibility to type 2 diabetes. Clin Lab, 62, 1553–1561.
4.
AssmannT.S., DuarteG.C., BrondaniL.A., de FreitasP.H., MartinsE.M., CananiL.H., et al. (2017). Polymorphisms in genes encoding miR-155 and miR-146a are associated with protection to type 1 diabetes mellitus. Acta Diabetol, 54, 433–441.
5.
BastamiM., GhaderianS.M., OmraniM.D., MirfakhraieR., VakiliH., ParsaS.A., et al. (2016). MiRNA-related polymorphisms in miR-146a and TCF21 are associated with increased susceptibility to coronary artery disease in an Iranian population. Genet Test Mol Biomarkers, 20, 241–248.
6.
BergstromI., LundbergA.K., JonssonS., SarndahlE., ErnerudhJ., and JonassonL. (2017). Annexin A1 in blood mononuclear cells from patients with coronary artery disease: its association with inflammatory status and glucocorticoid sensitivity. PLoS One, 12, e0174177.
7.
BokmaJ.P., ZegstrooI., KuijpersJ.M., KoningsT.C., van KimmenadeR.R.J., van MelleJ.P., et al. (2017). Factors associated with coronary artery disease and stroke in adults with congenital heart disease. Heart, 104, 574–580.
8.
BrunquellJ., SnyderA., ChengF., and WesterheideS.D. (2017). HSF-1 is a regulator of miRNA expression in Caenorhabditis elegans. PLoS One, 12, e0183445.
9.
ChenC., HongH., ChenL., ShiX., ChenY., and WengQ. (2014). Association of microRNA polymorphisms with the risk of myocardial infarction in a Chinese population. Tohoku J Exp Med, 233, 89–94.
10.
ChenH.C., TsengY.K., ChiC.C., ChenY.H., YangC.M., HuangS.J., et al. (2016). Genetic variants in microRNA-146a (C>G) and microRNA-1269b (G>C) are associated with the decreased risk of oral premalignant lesions, oral cancer, and pharyngeal cancer. Arch Oral Biol, 72, 21–32.
11.
ChenH.Y., ChenY.M., WuJ., YangF.C., LvZ., XuX.F., et al. (2017a). MIR196A2 rs11614913 C>T polymorphism correlates with an increased risk of hepatopulmonary syndrome in liver cirrhosis: a case-control study in China. Hepatol Res, 47, 793–802.
12.
ChenW., ShaoD., GuH., GongJ., and ZhangJ. (2017b). Hsa-mir-499 rs3746444 T/C polymorphism is associated with increased risk of coronary artery disease in a Chinese population. Acta Cardiol Sin, 33, 34–40.
13.
CiccacciC., ConigliaroP., PerriconeC., RufiniS., TriggianeseP., PolitiC., et al. (2016). Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis. Clin Exp Immunol, 186, 157–163.
14.
CiccacciC., LatiniA., GrecoC., PolitiC., D'AmatoC., LauroD., et al. (2018). Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes. J Diabetes Complications, 32, 11–17.
15.
FragosoJ.M., Ramirez-BelloJ., Martinez-RiosM.A., Pena-DuqueM.A., Posadas-SanchezR., Delgadillo-RodriguezH., et al. (2019). miR-196a2 (rs11614913) polymorphism is associated with coronary artery disease, but not with in-stent coronary restenosis. Inflamm Res, 68, 215–221.
16.
GuiL., WuF., HanX., DaiX., QiuG., LiJ., et al. (2014). A multilocus genetic risk score predicts coronary heart disease risk in a Chinese Han population. Atherosclerosis, 237, 480–485.
17.
HuangS., LvZ., DengQ., LiL., YangB., FengJ., et al. (2015a). A genetic variant in pre-miR-146a (rs2910164 C>G) is associated with the decreased risk of acute coronary syndrome in a Chinese population. Tohoku J Exp Med, 237, 227–233.
18.
HuangS., ZhouS., ZhangY., LvZ., LiS., XieC., et al. (2015b). Association of the genetic polymorphisms in pre-microRNAs with risk of ischemic stroke in a Chinese population. PLoS One, 10, e0117007.
19.
JinX., ChenD., ZhengR.H., ZhangH., ChenY.P., and XiangZ. (2017). miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism. World J Gastroenterol, 23, 76–86.
20.
KaidonisG., GilliesM.C., AbharyS., LiuE., EssexR.W., ChangJ.H., et al. (2016). A single-nucleotide polymorphism in the MicroRNA-146a gene is associated with diabetic nephropathy and sight-threatening diabetic retinopathy in Caucasian patients. Acta Diabetol, 53, 643–650.
21.
KlingelhofferC., CodrinC., EttlT., ReichertT., and MorsczeckC. (2016). miRNA-101 supports the osteogenic differentiation in human dental follicle cells. Arch Oral Biol, 72, 47–50.
22.
KucukhuseyinO., KurnazO., Akadam-TekerA.B., IsbirT., BugraZ., OzturkO., et al. (2013). The association of MTHFR C677T gene variants and lipid profiles or body mass index in patients with diabetic and nondiabetic coronary heart disease. J Clin Lab Anal, 27, 427–434.
23.
LandgrafP., RusuM., SheridanR., SewerA., IovinoN., AravinA., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401–1414.
24.
LermanJ.B., ParnessI.A., and ShenoyR.U. (2017). Body weights in adults with congenital heart disease and the obesity frequency. Am J Cardiol, 119, 638–642.
25.
LiQ., ChenL., ChenD., WuX., and ChenM. (2015). Influence of microRNA-related polymorphisms on clinical outcomes in coronary artery disease. Am J Transl Res, 7, 393–400.
26.
LiZ., BaiY., GuoX., ZhengL., SunY., and RoselleA.M. (2016). Alcohol consumption and cardiovascular diseases in rural China. Int J Cardiol, 215, 257–262.
LuS., WangM.S., ChenP.J., RenQ., and BaiP. (2017). miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6. Exp Ther Med, 13, 3309–3314.
29.
LuiG.K., RogersI.S., DingV.Y., HedlinH.K., MacMillenK., MaronD.J., et al. (2017). Risk estimates for atherosclerotic cardiovascular disease in adults with congenital heart disease. Am J Cardiol, 119, 112–118.
30.
LuoC., WangX.Q., ChenL.K., YinJ.W., ChenS.J., LiuL.G. (2019). [Association between plasma selenium and the risk of impaired glucose regulation]. Zhonghua Yu Fang Yi Xue Za Zhi, 53, 565–569.
31.
LuthraR., SinghR.R., LuthraM.G., LiY.X., HannahC., RomansA.M., et al. (2008). MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene, 27, 6667–6678.
32.
MavesC.K., JohnsonJ.F., BoveK., and MalottR.L. (1989). Gastric inflammatory pseudotumor in children. Radiology, 173, 381–383.
33.
McDonaldR.A., HallidayC.A., MillerA.M., DiverL.A., DakinR.S., MontgomeryJ., et al. (2015). Reducing in-stent restenosis: therapeutic manipulation of miRNA in vascular remodeling and inflammation. J Am Coll Cardiol, 65, 2314–2327.
34.
MoonJ.R., SongJ., HuhJ., KangI.S., ParkS.W., ChangS.A., et al. (2015). Analysis of cardiovascular risk factors in adults with congenital heart disease. Korean Circ J, 45, 416–423.
35.
NewtonJ.N., BriggsA.D., MurrayC.J., DickerD., ForemanK.J., WangH., et al. (2015). Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386, 2257–2274.
36.
NoonanE.J., PlaceR.F., BasakS., PookotD., and LiL.C. (2010). miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget, 1, 349–358.
37.
PanarelliN.C., and YantissR.K. (2011). MicroRNA expression in selected carcinomas of the gastrointestinal tract. Patholog Res Int, 2011, 124608.
38.
ParkR., LeeW.J., and JiJ.D. (2016). Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: a meta-analysis. Autoimmunity, 49, 451–458.
39.
QiuH., ChengC., WangY., KangM., TangW., ChenS., et al. (2016). Investigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjects. Onco Targets Ther, 9, 6641–6650.
40.
ShakerO.G., El BoghdadyN.A., and El SayedA.E. (2018). Association of MiRNA-146a, MiRNA-499, IRAK1 and PADI4 polymorphisms with rheumatoid arthritis in Egyptian population. Cell Physiol Biochem, 46, 2239–2249.
41.
SibinM.K., HarshithaS.M., NarasingaraoK.V., DhananjayaI.B., DhavalP.S., and ChetanG.K. (2017). Effect of rs11614913 polymorphism on mature miR196a2 expression and its target gene HOXC8 expression in human glioma. J Mol Neurosci, 61, 144–151.
42.
SoderstromE., EliassonM., JohnsonO., HallmansG., WeinehallL., JanssonJ.H., et al. (2013). Plasma folate, but not homocysteine, is associated with apolipoprotein A1 levels in a non-fortified population. Lipids Health Dis, 12, 74.
43.
SunQ., GuH., ZengY., XiaY., WangY., JingY., et al. (2010). Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci, 101, 2241–2247.
44.
SungJ.H., KimS.H., YangW.I., KimW.J., MoonJ.Y., KimI.J., et al. (2016). miRNA polymorphisms (miR146a, miR149, miR196a2 and miR499) are associated with the risk of coronary artery disease. Mol Med Rep, 14, 2328–2342.
45.
TangW., ChenS., ChenY., LinJ., LinJ., WangY., et al. (2017). Programmed death-1 polymorphisms is associated with risk of esophagogastric junction adenocarcinoma in the Chinese Han population: a case-control study involving 2,740 subjects. Oncotarget, 8, 39198–39208.
46.
TangW., QiuH., DingH., SunB., WangL., YinJ., et al. (2013). Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects. PLoS One, 8, e82790.
47.
TangW., QiuH., JiangH., SunB., WangL., YinJ., et al. (2014a). Lack of association between cytotoxic T-lymphocyte antigen 4 (CTLA-4) -1722T/C (rs733618) polymorphism and cancer risk: from a case-control study to a meta-analysis. PLoS One, 9, e94039.
48.
TangW., QiuH., JiangH., WangL., SunB., and GuH. (2014b). Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects. PLoS One, 9, e90328.
49.
TangW., WangY., ChenS., LinJ., ChenB., YuS., et al. (2016). Investigation of cytotoxic T-lymphocyte antigen 4 polymorphisms in gastric cardia adenocarcinoma. Scand J Immunol, 83, 212–218.
50.
TangW., WangY., PanH., QiuH., and ChenS. (2019). Association of miRNA-499 rs3746444 A>G variants with adenocarcinoma of esophagogastric junction (AEG) risk and lymph node status. Onco Targets Ther, 12, 6245–6252.
51.
TangW., ZhangS., QiuH., WangL., SunB., YinJ., et al. (2014c). Genetic variations in MTHFR and esophageal squamous cell carcinoma susceptibility in Chinese Han population. Med Oncol, 31, 915.
52.
ThakurN., SinghalP., MehrotraR., and BharadwajM. (2019). Impacts of single nucleotide polymorphisms in three microRNAs (miR-146a, miR-196a2 and miR-499) on the susceptibility to cervical cancer among Indian women. Biosci Rep, 39, pii: BSR20180723.
53.
ToraihE.A., IsmailN.M., ToraihA.A., HusseinM.H., and FawzyM.S. (2016). Precursor miR-499a variant but not miR-196a2 is associated with rheumatoid arthritis susceptibility in an Egyptian population. Mol Diagn Ther, 20, 279–295.
54.
VasudevanS., TongY., and SteitzJ.A. (2007). Switching from repression to activation: microRNAs can up-regulate translation. Science, 318, 1931–1934.
55.
WangY., ChenS., KangM., TangW., GuH., YinJ., et al. (2015). Genetic variations in MTHFR and gastric cardia adenocarcinoma susceptibility in the Chinese Han population. Int J Clin Exp Med, 8, 18936–18944.
56.
WangY., LiQ., MambiyaM., ZhangK., YangL., ZhangQ., et al. (2018). A meta-analysis of the association between Microrna-196A2 and risk of ischemic stroke and coronary artery disease in Asian population. J Stroke Cerebrovasc Dis, 27, 3008–3019.
57.
WangY., ZhaoM., LiuJ., SunZ., NiJ., and LiuH. (2017). miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3beta signaling pathway. Oncol Rep, 38, 1715–1723.
58.
XiongX.D., ChoM., CaiX.P., ChengJ., JingX., CenJ.M., et al. (2014). A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutat Res, 761, 15–20.
59.
XuJ., HuZ., XuZ., GuH., YiL., CaoH., et al. (2009). Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum Mutat, 30, 1231–1236.
60.
YinZ., CuiZ., RenY., XiaL., LiH., and ZhouB. (2017a). MiR-146a polymorphism correlates with lung cancer risk in Chinese nonsmoking females. Oncotarget, 8, 2275–2283.
61.
YinZ., CuiZ., RenY., XiaL., LiH., and ZhouB. (2017b). MiR-196a2 and lung cancer in Chinese non-smoking females: a genetic association study and expression analysis. Oncotarget, 8, 70890–70898.
62.
YuJ., WuS.W., and WuW.P. (2017). A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2. Am J Transl Res, 9, 3336–3344.
63.
ZhaiY., ZhaoW.H., and ChenC.M. (2010). [Verification on the cut-offs of waist circumference for defining central obesity in Chinese elderly and tall adults]. Zhonghua Liu Xing Bing Xue Za Zhi, 31, 621–625.
64.
ZhangY., YuY., YuanY., YuK., YangH., LiX., et al. (2017). Association of drinking pattern with risk of coronary heart disease incidence in the middle-aged and older Chinese men: results from the Dongfeng-Tongji cohort. PLoS One, 12, e0178070.
65.
ZhaoH., XuJ., ZhaoD., GengM., GeH., FuL., et al. (2016). Somatic mutation of the SNP rs11614913 and its association with increased MIR 196A2 expression in breast cancer. DNA Cell Biol, 35, 81–87.
66.
ZhiH., WangL., MaG., YeX., YuX., ZhuY., et al. (2012). Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease. Clin Res Cardiol, 101, 289–296.
67.
ZhuH., ZhangH., BaoL., and DaiM. (2017a) [Analysis of association of genetic polymorphisms of microRNAs with ischemic stroke]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 34, 261–265.
68.
ZhuL., HuangQ., XieZ., KangM., DingH., ChenB., et al. (2017b). PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level. Oncotarget, 8, 37308–37320.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
